Cargando…
Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens
Several point-of-care (POC) molecular tests have received emergency use authorization (EUA) from the Food and Drug Administration (FDA) for the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The test performance characteristics of the Accula (Mesa Biotech) SARS-CoV-2 POC...
Autores principales: | Hogan, Catherine A., Garamani, Natasha, Lee, Andrew S., Tung, Jack K., Sahoo, Malaya K., Huang, ChunHong, Stevens, Bryan, Zehnder, James, Pinsky, Benjamin A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383558/ https://www.ncbi.nlm.nih.gov/pubmed/32461285 http://dx.doi.org/10.1128/JCM.01072-20 |
Ejemplares similares
-
Plasma as an alternative COVID-19 diagnostic specimen in a hospitalized patient negative for SARS-CoV-2 by nasopharyngeal swab
por: Lawrence, Lauren, et al.
Publicado: (2021) -
Five-minute point-of-care testing for SARS-CoV-2: Not there yet
por: Hogan, Catherine A., et al.
Publicado: (2020) -
Retrospective Screening for SARS-CoV-2 RNA in California, USA, Late 2019
por: Hogan, Catherine A., et al.
Publicado: (2020) -
Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2
por: Hogan, Catherine A., et al.
Publicado: (2020) -
Pooled Saliva Specimens for SARS-CoV-2 Testing
por: Barat, Bidisha, et al.
Publicado: (2021)